Filed: 2/14/2023ACC: 0001104659-23-020042
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 46 equity positions with a total reported market value of $1.69B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
46
Positions
$1.69B
Total AUM (reported)
77.20M
Total Shares
Allocation by class
COM$1.27B75.5%
SPONSORED ADR$248.06M14.7%
CL A$99.25M5.9%
SHS$64.45M3.8%
COMMON SHARES$1.58M0.1%
Portfolio Concentration
Top 3$642.05M38.1%
4–10$498.27M29.6%
11–25$413.28M24.5%
Rest$131.62M7.8%
Top 3 weight
38.1%
Top 10 weight
67.7%
Voting Authority Distribution
Total shares with voting rights: 77.20M
Sole
Full voting authority
77.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole46
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings46
Rows:
Karuna Therapeutics Inc
SOLEShares2.07M
TypeSH
Market value$407.37M
24.17%
Sole
2.07M
Shared
0.00
None
0.00
Natera Inc
SOLEShares3.10M
TypeSH
Market value$124.55M
7.39%
Sole
3.10M
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$110.13M
6.54%
Sole
3.76M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares880.80K
TypeSH
Market value$107.57M
6.38%
Sole
880.80K
Shared
0.00
None
0.00
Sanofi SA
SOLEShares1.97M
TypeSH
Market value$95.19M
5.65%
Sole
1.97M
Shared
0.00
None
0.00
Cincor Pharma Inc
SOLEShares6.07M
TypeSH
Market value$74.65M
4.43%
Sole
6.07M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares603.36K
TypeSH
Market value$66.94M
3.97%
Sole
603.36K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.18M
TypeSH
Market value$61.56M
3.65%
Sole
3.18M
Shared
0.00
None
0.00
Horizon Therapeutics PLC
SOLEShares413.17K
TypeSH
Market value$47.02M
2.79%
Sole
413.17K
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares156.99K
TypeSH
Market value$45.34M
2.69%
Sole
156.99K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares613.67K
TypeSH
Market value$41.61M
2.47%
Sole
613.67K
Shared
0.00
None
0.00
Biomarin Pharmaceutical Inc
SOLEShares394.64K
TypeSH
Market value$40.84M
2.42%
Sole
394.64K
Shared
0.00
None
0.00
Reata Pharmaceuticals Inc
SOLEShares992.03K
TypeSH
Market value$37.69M
2.24%
Sole
992.03K
Shared
0.00
None
0.00
Alnylam Pharmaceuticals Inc
SOLEShares156.45K
TypeSH
Market value$37.18M
2.21%
Sole
156.45K
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares247.96K
TypeSH
Market value$32.13M
1.91%
Sole
247.96K
Shared
0.00
None
0.00
CTI Biopharma Corp
SOLEShares5.02M
TypeSH
Market value$30.15M
1.79%
Sole
5.02M
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares608.93K
TypeSH
Market value$27.90M
1.66%
Sole
608.93K
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares1.11M
TypeSH
Market value$27.35M
1.62%
Sole
1.11M
Shared
0.00
None
0.00
United Therapeutics Corp
SOLEShares89.21K
TypeSH
Market value$24.81M
1.47%
Sole
89.21K
Shared
0.00
None
0.00
Chinook Therapeutics Inc
SOLEShares806.46K
TypeSH
Market value$21.13M
1.25%
Sole
806.46K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc
SOLEShares1M
TypeSH
Market value$20.22M
1.20%
Sole
1M
Shared
0.00
None
0.00
Prometheus Biosciences Inc
SOLEShares176.54K
TypeSH
Market value$19.42M
1.15%
Sole
176.54K
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares703.07K
TypeSH
Market value$17.89M
1.06%
Sole
703.07K
Shared
0.00
None
0.00
Align Technology Inc
SOLEShares83.10K
TypeSH
Market value$17.53M
1.04%
Sole
83.10K
Shared
0.00
None
0.00
Immatics NV
SOLEShares2M
TypeSH
Market value$17.43M
1.03%
Sole
2M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 2.07M | SH | $407.37M 24.17% | 2.07M | 0.00 | 0.00 |
Natera IncSOLE | COM | 3.10M | SH | $124.55M 7.39% | 3.10M | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $110.13M 6.54% | 3.76M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 880.80K | SH | $107.57M 6.38% | 880.80K | 0.00 | 0.00 |
Sanofi SASOLE | SPONSORED ADR | 1.97M | SH | $95.19M 5.65% | 1.97M | 0.00 | 0.00 |
Cincor Pharma IncSOLE | COM | 6.07M | SH | $74.65M 4.43% | 6.07M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 603.36K | SH | $66.94M 3.97% | 603.36K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.18M | SH | $61.56M 3.65% | 3.18M | 0.00 | 0.00 |
Horizon Therapeutics PLCSOLE | SHS | 413.17K | SH | $47.02M 2.79% | 413.17K | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | COM | 156.99K | SH | $45.34M 2.69% | 156.99K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 613.67K | SH | $41.61M 2.47% | 613.67K | 0.00 | 0.00 |
Biomarin Pharmaceutical IncSOLE | COM | 394.64K | SH | $40.84M 2.42% | 394.64K | 0.00 | 0.00 |
Reata Pharmaceuticals IncSOLE | CL A | 992.03K | SH | $37.69M 2.24% | 992.03K | 0.00 | 0.00 |
Alnylam Pharmaceuticals IncSOLE | COM | 156.45K | SH | $37.18M 2.21% | 156.45K | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 247.96K | SH | $32.13M 1.91% | 247.96K | 0.00 | 0.00 |
CTI Biopharma CorpSOLE | COM | 5.02M | SH | $30.15M 1.79% | 5.02M | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM | 608.93K | SH | $27.90M 1.66% | 608.93K | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 1.11M | SH | $27.35M 1.62% | 1.11M | 0.00 | 0.00 |
United Therapeutics CorpSOLE | COM | 89.21K | SH | $24.81M 1.47% | 89.21K | 0.00 | 0.00 |
Chinook Therapeutics IncSOLE | COM | 806.46K | SH | $21.13M 1.25% | 806.46K | 0.00 | 0.00 |
Zentalis Pharmaceuticals IncSOLE | COM | 1M | SH | $20.22M 1.20% | 1M | 0.00 | 0.00 |
Prometheus Biosciences IncSOLE | COM | 176.54K | SH | $19.42M 1.15% | 176.54K | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 703.07K | SH | $17.89M 1.06% | 703.07K | 0.00 | 0.00 |
Align Technology IncSOLE | COM | 83.10K | SH | $17.53M 1.04% | 83.10K | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 2M | SH | $17.43M 1.03% | 2M | 0.00 | 0.00 |
Page 1 of 2